Last reviewed · How we verify
NCT07155785: Lidocaine IUD
The Role of Lidocaine Spray in Reducing Pain During Intrauterine Device Application
NA trial testing Lidocain spray in Intrauterine Device Migration in 90 participants. Completed in 25 May 2023.
20 February 2023
Quick facts
| Lead sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 1 July 2022 |
| Primary completion | 20 February 2023 |
| Estimated completion | 25 May 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Lidocain spray
Conditions studied
- Intrauterine Device Migration — all drugs for Intrauterine Device Migration →
- Pain — all drugs for Pain →
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Who can join
Adults 18 to 45, female only, with Intrauterine Device Migration or Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators aimed to investigate the effectiveness of the use of local lidocaine spray application to make routine intrauterine intrauterine device application more painless.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The role of lidocaine spray in reducing pain during intrauterine device insertion.
Demircivi E, Yildirim A, Ozel CS, Sari S, et al · · 2026 · PMID 41612302 · DOI 10.1186/s12905-026-04296-3 -
The Role Of Lidocaine Spray In Reducing Pain During Intrauterine Device Insertion
DEMIRCIVI E, YILDIRIM A, OZEL CS, SARI S, et al · · 2025 · DOI 10.21203/rs.3.rs-7772208/v1
Verify or expand the search:
- PubMed search for NCT07155785
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lidocain spray
Trials testing the same drug.
- NCT07212192 — Effectiveness of 10% Lidocaine on Relieving Pain Caused by Intravenous Intubation · Phase 3 · not yet recruiting
Other Kanuni Sultan Suleyman Training and Research Hospital trials
Trials by the same sponsor.
- NCT07519551 — Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength · not yet recruiting
- NCT07480330 — Serum Neurofilament Light Chain Levels and Neuropathy Severity in Diabetic Polyneuropathy · not yet recruiting
- NCT07425405 — Daily Screen Exposure and Preoperative Anxiety in Children Aged 2-5 Years · recruiting
- NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
- NCT07261436 — Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07155785 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kanuni Sultan Suleyman Training and Research Hospital
- Last refreshed: 4 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07155785.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing